Back to top
more

P3 Health Partners (PIII)

(Delayed Data from NSDQ)

$0.45 USD

0.45
469,425

-0.03 (-7.02%)

Updated Apr 26, 2024 04:00 PM ET

After-Market: $0.45 0.00 (0.85%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value C Growth B Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 34% (85 out of 252)

Industry: Medical Info Systems

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Balance Sheet

Research for PIII

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

 

Fiscal Year End for P3 Health Partners Inc falls in the month of December.

All items in Millions except Per Share data.

12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Assets          
Cash & Equivalents 41 18 141 0 0
Receivables 121 80 52 0 0
Notes Receivable 0 0 0 0 0
Inventories 0 0 0 0 0
Other Current Assets 4 3 7 0 0
Total Current Assets 166 101 200 0 0
Net Property & Equipment 9 9 8 0 0
Investments & Advances 0 0 0 0 0
Other Non-Current Assets 0 0 4 0 0
Deferred Charges 0 0 0 0 0
Intangibles 667 751 2,146 0 0
Deposits & Other Assets 20 16 0 0 0
Total Assets 861 877 2,364 0 0
Liabilities & Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Notes Payable 0 26 0 0 0
Accounts Payable 222 176 142 0 0
Current Portion Long-Term Debt 0 0 4 0 0
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 64 39 15 0 0
Income Taxes Payable 0 0 0 0 0
Other Current Liabilities 14 0 38 0 0
Total Current Liabilities 299 242 199 0 0
Mortgages 0 0 0 0 0
Deferred Taxes/Income 0 0 0 0 0
Convertible Debt 0 0 0 0 0
Long-Term Debt 108 94 80 0 0
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 6 6 15 0 0
Minority Interest (Liabilities) 292 517 1,791 0 0
Total Liabilities 719 871 2,091 0 0
Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Preferred Stock 0 0 0 0 0
Common Stock (Par) 0 0 0 0 0
Capital Surplus 509 315 313 0 0
Retained Earnings -367 -310 -39 0 0
Other Equity 0 0 0 0 0
Treasury Stock 0 0 0 0 0
Total Shareholder's Equity 142 6 274 0 0
Total Liabilities & Shareholder's Equity 861 877 2,364 0 0
Total Common Equity 142 6 274 0 0
Shares Outstanding 313.10 40.30 40.30 7.90 NA
Book Value Per Share 0.45 0.15 6.79 0.00 0.00

Fiscal Year End for P3 Health Partners Inc falls in the month of December.

All items in Millions except Per Share data.

3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Assets          
Cash & Equivalents -99,999 41 57 66 8
Receivables NA 121 119 104 98
Notes Receivable NA 0 0 0 0
Inventories NA 0 0 0 0
Other Current Assets NA 4 3 2 3
Total Current Assets NA 166 180 172 109
Net Property & Equipment NA 9 9 10 9
Investments & Advances NA 0 0 0 0
Other Non-Current Assets NA 0 0 0 0
Deferred Charges NA 0 0 0 0
Intangibles NA 667 688 709 730
Deposits & Other Assets NA 20 20 18 19
Total Assets NA 861 897 909 867
Liabilities & Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Notes Payable NA 0 0 0 0
Accounts Payable NA 222 203 175 193
Current Portion Long-Term Debt NA 0 0 0 0
Current Portion Capital Leases NA 0 0 0 0
Accrued Expenses NA 64 48 46 45
Income Taxes Payable NA 0 0 0 0
Other Current Liabilities NA 14 17 30 32
Total Current Liabilities NA 299 267 250 270
Mortgages NA 0 0 0 0
Deferred Taxes/Income NA 0 0 0 0
Convertible Debt NA 0 0 0 0
Long-Term Debt NA 108 108 108 108
Non-Current Capital Leases NA 0 0 0 0
Other Non-Current Liabilities NA 7 8 6
Minority Interest (Liabilities) NA 292 313 667 474
Total Liabilities NA 719 709 1,045 870
Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Preferred Stock NA 0 0 0 0
Common Stock (Par) NA 0 0 0 0
Capital Surplus NA 509 530 192 316
Retained Earnings NA -367 -342 -329 -319
Other Equity NA 0 0 0 0
Treasury Stock NA 0 0 0 0
Total Shareholder's Equity NA 142 188 -136 -3
Total Liabilities & Shareholder's Equity NA 861 897 909 867
Total Common Equity 0 142 188 -136 -3
Shares Outstanding 315.90 313.10 312.60 312.60 243.40
Book Value Per Share 0.00 0.45 0.60 -0.44 -0.01